Date published: 2026-6-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

EBV Bam HI Z Antibody (5E265): sc-71021

2.0(1)
Write a reviewAsk a question

Datasheets
  • EBV Bam HI Z Antibody (5E265) is a mouse monoclonal IgG2*** EBV Bam HI Z antibody provided at 100 µg/ml
  • raised against EBV Bam HI Z from an infected cell lysate
  • recommended for detection of Bam HI Z of Epstein-Barr Virus origin by WB, IP and IF
  • At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for EBV Bam HI Z Antibody (5E265). This work is in progress.
    Gene Editing Promo Banner

    QUICK LINKS

    SEE ALSO...

    EBV Bam HI Z Antibody (5E265) is a mouse monoclonal IgG2 antibody that detects the EBV Bam HI Z protein of Epstein-Barr Virus origin by western blotting (WB), immunoprecipitation (IP), and immunofluorescence (IF). Anti-EBV Bam HI Z antibody (5E265) is available as the non-conjugated format. EBV Bam HI Z protein plays a crucial role in the viral life cycle, particularly through association with the BZLF1 gene, which is essential for the transition from latent to lytic infection. This switch allows viral replication and spread, contributing to the pathogenesis of diseases such as infectious mononucleosis and various malignancies, including Burkitt lymphoma and nasopharyngeal carcinoma. Immediate early expression of EBV Bam HI Z protein is vital for initiating the lytic cycle, making EBV Bam HI Z (5E265) antibody a key tool for understanding EBV′s biology and impact on human health. Research using EBV Bam HI Z monoclonal antibody (5E265) can provide insights into the mechanisms of EBV infection and associated diseases, enhancing our understanding of this prevalent virus.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

    Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

    LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

    EBV Bam HI Z Antibody (5E265) References:

    1. Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma.  |  Ruf, IK., et al. 1999. Mol Cell Biol. 19: 1651-60. PMID: 10022853
    2. Epstein-Barr Viral Antigens Used in the Diagnosis of Nasopharyngeal Carcinoma.  |  Gan, YY., et al. 1996. J Biomed Sci. 3: 159-169. PMID: 11725096
    3. Characterization of T-cell non-Hodgkin's lymphoma and its association with Epstein-Barr virus in Pakistani patients.  |  Noorali, S., et al. 2003. Leuk Lymphoma. 44: 807-13. PMID: 12802918
    4. Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells.  |  Spender, LC., et al. 2006. J Gen Virol. 87: 2859-2867. PMID: 16963743
    5. Serodiagnosis of infectious mononucleosis by using recombinant Epstein-Barr virus antigens and enzyme-linked immunosorbent assay technology.  |  Gorgievski-Hrisoho, M., et al. 1990. J Clin Microbiol. 28: 2305-11. PMID: 2172287
    6. Characterization of the restricted component of Epstein-Barr virus early antigens as a cytoplasmic filamentous protein.  |  Luka, J., et al. 1986. J Virol. 58: 748-56. PMID: 2422401
    7. Neutralization of Epstein-Barr virus-induced ribonucleotide reductase with antibody to the major restricted early antigen polypeptide.  |  Goldschmidts, WL., et al. 1989. Virology. 170: 330-3. PMID: 2541553
    8. [Studies on tissue distribution and expression of Epstein-Barr virus using polymerase chain reaction].  |  Oikawa, O. 1995. Hokkaido Igaku Zasshi. 70: 729-42. PMID: 8543279
    9. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.  |  Wen, W., et al. 2007. J Virol. 81: 1037-42. PMID: 17079287

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    EBV Bam HI Z Antibody (5E265)

    sc-71021
    100 µg/ml
    $322.00